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Abstract An extracellular portion of granulocyte colony-stimulating factor (G-CSF) receptor, which contains an immunoglobulin-like (Ig) domain 
and cytokine receptor homologous (CRH) region, was secreted into the medium using Trichoplwia ni-Autographa californica nuclear polyhedrosis 
virus system. The gene product was purified to homogeneity mainly as a dimer (85 kDa) using G-CSF affinity column chromatography and gel 
filtration HPLC, although the product existed as a monomer (45 kDa) in the medium. Scatchard analyses uggested that only the dimer had high 
aBinity ligand binding (& = about 100 PM), which is comparable with the Kd value of the cell surface. receptor. The binding of G-CSF to Ig-CRH 
induced its tetramerization (200-250 kDa). The molecular composition of the tetrameric omplex showed a stoichiometry of four ligands bound to 
four Ig-CRH. These results suggested that the oligomeric mechanism of the G-CSF receptor differs from that reported for growth hormone (GH) 
receptor, although CD spectrum spectroscopy suggested that the Ig-CRH has a GH receptor-like structure. 
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1. Introduction 
Ligand induced receptor oligomerization has been proposed 
as the key mechanism of signal transduction for a family of 
single transmembrane receptors such as cytokine receptors and 
tyrosine kinase-type receptors [1,2]. In models, oligomerization 
of extracellular portions induced by their ligand binding are 
followed by activation of their cytoplasmic regions. For de- 
tailed studies of the oligomerization mechanism of receptors, 
it is essential to analyze the molecular basis of their extracellu- 
lar portion in solution. 
Granulocyte colony-stimulating factor (G-CSF) receptor is 
a member of a family of receptors for various cytokines, such 
as interleukins 2-7, erythropoietin, growth hormone (GH), in- 
terferons a, B, y and prolactin [3]. A requirement for dimeriza- 
tion of the cytoplasmic region of the G-CSF receptor for the 
signal transduction has been suggested using a chimera with the 
GH receptor [4,5]. The extracellular region (-600 amino acid 
residues) of the G-CSF receptor has a composite structure 
containing an immunoglobulin-like (Ig) domain, a cytokine 
receptor homologous (CRH) region, and three fibronectin type 
III-like domains [6,7]. The amino terminal domain (- 100 amino 
acid residues) of CRH has been expressed as a minimun ligand 
binding unit using E. coli system [8]. The purified domain exhib- 
ited ligand binding activity, but it did not form an oligomeric 
structure [8]. Deletion analyses using the cDNA of G-CSF 
receptor have indicated that the cDNA encoding the Ig domain 
and the CRH region (Ig-CRH; - 300 amino acid residues) as the 
ligand binding unit had almost the same the ligand binding 
activity as the wild type cDNA [9]. Thus, we expressed Ig-CRH 
to analyze the oligomerization. 
Here, we describe the expression of a gene encoding the 
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Ig-CRH of the G-CSF receptor extracellular portion using a 
Trichoplusia ni-Autographa californica nuclear polyhedrosis 
virus system to analyze the oligomerization mechanism of the 
G-CSF receptor. The expressed Ig-CRH was purified mainly 
as a dimer. Furthermore, the Ig-CRH was converted to a tetra- 
mer by G-CSF. 
2. Materials and methods 
2.1. Production of recombinant baculovirus carrying the gene encoding 
Ig-CRH of &SF receptor 
The DNA encodine the murine Ie-CRH of G-CSF receptor and its 
signal seouence was amplified by the polymerase chain reaction from 
plasmid pBLJl7 codingthe mu&e GICSF receptor (Fig. 1A) [6]. The 
5’ sense mimer had the seauence S-CGGGATCCATGGTAGGGC- 
TGGGA’GCCTG-3’, whichcontains the BumHI site at the amino ter- 
minus, followed by the coding sequence for the murine G-CSF receptor 
starting from Mett2’. The 3’-antisense primer has the sequence 5’- 
GCGGATCCTTAGGCCTTCATGGTAGGCCTCA-3’, which con- 
tains the coding sequence for AlaM of the G-CSF receptor, followed 
by a stop codon and the BamHI site. The transfer vector pAcIg-CRH 
was obtained bv the insertion of the amplified DNA into a BumHI site 
of a plasmid pAcYMl[lO], which carries part of the genome of Autogra- 
pha californica nuclear polyhedrosis virus. The Barn HI site in pAcYM1 
had been inserted downstream of the polyhedrin promoter. A recombi- 
nant virus AcIg-CRH carrying the Ig-CRH gene was produced by in 
vivo homologous DNA recombination using the transfer vector pAcIg- 
CRH, as described [11,12]. 
2.2. Expression and purification of the Ig-CRH 
Trichoplusia ni cells (Invitrogen; High Five Cells) cultured to conflu- 
ence were diluted IO-fold with Sf-900 II SFM medium (GIBCO) and 
incubated at 27’C for one day in a 225-cm’flask (Costar) Culture cells 
were infected with the recombinant virus AcIg-CRH and cultured for 
9 days at 18’C. The culture supematant was passed over a G-CSF 
affinity column (1 x 5 cm; prepared as described by Fukunaga et al.) 
1131. then washed thoroughly with phosphate buffered saline. The pro- 
tein was eluted in a stepwise manner, with 0.1 M glycine-HCl buffer pH 
2.0 containing 0.2 M NaCl. The eluted protein was immediately neu- 
tralized with 2 M Trizma base and applied to a gel liltration HPLC 
column (7.6-mm. inner diameter. x60 cm: TSKeel G3000 SW HPLC 
column; TOSO Co., Ltd) equilibrated with 20 mM sodium phosphate 
buffer, pH 7.0, containing 0.2 M NaCl. The sample was eluted with the 
same solution at a flow rate of 0.5 ml/min, and the fractions containing 
the Ig-CRH were collected. 
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2.3. G-CSF Binding to Ig-CRH 
A ‘251-G-CSF binding assay was performed by means of gel filtration. 
The Ig-CRH was mixed with ‘251-G-CSF (up to 200,000 cpm) in 50 ~1 
of 50 mM sodium phosphate buffer (pH 7.0). The binding reaction 
proceeded for 90 min at room temperature. Thereafter, the mixture was 
applied to TSKgel G3000SW HPLC equilibrated with 20 mM sodium 
phosphate buffer (oH 7.0) containine 0.2 M NaCl and eluted with the - _ Y , 
same buffer at 0.5 ml/min. The Ig-CRH “‘1-G-CSF complex was ana- 
lyzed by the tracing the radioactivity using a y-counter (Packard, 
AUTO-GAMMA model A5002 COBRA). The assay used for 
Scatchard analysis of the Ig-CRH was essentially that as described by 
Fukunaga et al. [13]. The Ig-CRH was mixed with various concentra- 
tions (10 pM to 1 nM) of rz51-G-CSF (Amersham International, plc.) 
in 50 ~1 of phosphate buffered saline containing 10% fetal calf serum 
and 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-l-propanesufonic 
acid in the presence or absence of 500 nM unlabeled G-CSF. The 
binding reaction proceeded for 90 min at room temperature. After 
incubation, the IpCRH G-CSF complex was precipitated with carrier 
protein (y-globulin) by 15% (w/v) polyethylene glycol6000. The radio- 
activity in the precipitate was measured using the y-counter as 
described above. 
3. Results and discussion 
3.1. Expression and Purification of Ig-CRH using insect 
baculovirus secretion system 
Culture fluid of Trichoplusia ni cells infected with the recom- 
binant virus AcIg-CRH was applied to a G-CSF affinity col- 
umn and the G-CSF binding activity was eluted by the glycine- 
HCl buffer, pH 2.0. When the eluted material was analyzed by 
polyacrylamide gel electrophoresis in the presence of sodium 
dodecyl sulfate (SDS-PAGE), an homogenous 45 kDa band 
was identified (Fig. 1B). Western blotting using anti-Ml serum 
specific for the CRH of the G-CSF receptor [9] identified the 
same 45 kDa band (Fig. 1B). The 45 kDa band identified by 
Western blotting in the culture fluid disappeared upon adding 
tunicamycin, a glycosylated inhibitor, to the culture medium 
after infection and there was a corresponding increase in the 
4@42 kDa band in the cell extract. The molecular mass of 
40-42 kDa is similar to the molecular weight of the monomeric 
form of the Ig-CRH deduced from the DNA sequence [6]. 
These results indicated that the 45 kDa band was the glycosyl- 
ated Ig-CRH, because the Ig-CRH has five potential Asn- 
linked glycosylation sites [6]. 
The affinity purified protein was further chromatographed 
by gel filtration HPLC. As shown in Fig. lC, the protein was 
eluted mainly at a position of a molecular mass of 85 kDa as 
well as two minor proteins having a molecular mass corre- 
sponding to 45 and 200-250 kDa (Fig. 1C). The positions of 
the eluted peaks suggested that the purified Ig-CRH existed as 
monomer, dimer and tetramer. SDS-PAGE and Western blot- 
ting confirmed that all three peaks identified as the homoge- 
nous 45 kDa band. Contamination of the G-CSF into all three 
peaks during the G-CSF affinity chromatography was not de- 
tected. The product in the culture fluid on the gel filtration 
HPLC was eluted at the position of 45 kDa, suggesting that 
Ig-CRH was secreted as a monomer (identified by the Western 
blotting and i2’I-G-CSF binding activity). Thus, the dimeric 
and tetrameric forms were generated by the G-CSF affinity 
column chromatography. The dimer as the main product was 
re-chromatographed by gel filtration and used for further ex- 
periments. About 0.2-0.5 mg of purified dimeric Ig-CRH was 
constantly obtained per liter of culture. 
3.2. Initial characterization of the dimeric Ig-CRH 
Only one amino-terminal amino acid sequence detected in 
purified protein was identified as CGHISPP by direct amino 
acid sequencing on an Applied Biosystems automated gas- 
phase sequencer. This sequence was the same as that of the 
amino-terminus of the receptor for G-CSF deduced from the 
murine G-CSF receptor cDNA sequence [6], confirming that 
the purified protein was the Ig-CRH. The results also indicated 
that Trichoplusiu ni cells recognized and correctly cleaved the 
mammalian signal sequence. The far UV CD spectrum of the 
Ig-CRH exhibited positive ellipticity at 230 nm and negative 
ellipticity around 210 nm (data not shown). This was basically 
similar to the spectrum of the intact extracellular egion of the 
human GH receptor [14], although the latter is composed of a 
CRH region and lacks the Ig-like region. The extracellular 
region of the human GH receptor is composed of b-sheets and 
turns that are held together by disulfide bonds, and which lack 
an a-helix [ 151. A similar CD spectrum has also been found for 
the amino-terminal domain of the CRH region of the G-CSF 
receptor [8]. These results suggested that the Ig-CRH has a GH 
recentor-like structure. 
Scatchard analysis of ‘251-G-CSF binding data showed that 
the dimeric Ig-CRH has two classes of affinity, termed ‘high’ 
(Kd = approximately 100 PM), and ‘low’ (Kd = approximately 
2.5 nM). In contrast, the gene product secreted into the culture 
medium seemed to be a monomer (45 kDa; detected by gel 
filtration HPLC, Western blotting and G-CSF binding activ- 
ity), and exhibited low affinity ligand binding. These results 
suggested that the high affinity ligand binding was induced by 
the dimerization of the purified protein. The G-CSF binds on 
the cell surface only with high ligand affinity [13]. Thus, it 
appeared that the G-CSF receptor on cells are not monomers 
and ligand binding is not required for the dimerization of the 
G-CSF receptor in vivo. In solution, the dimer may exist as two 
forms, because of the low ligand affinity found in the purified 
dimer. These data were consistent with the results of the native 
receptor purified from the mouse myeloid leukemia cell line 
NSF-60, indicating that the monomer (100-l 30 kDa) exhibited 
low affinity ligand binding, whereas oligomeric forms (200 kDa 
and larger) have the low and the high affinity ligand binding 
[13]. As described above, we purified a trace amount of tetra- 
merit Ig-CRH as well as the monomer. This tetrameric Ig-CRH 
retained the G-CSF binding activity. This tetramer may corre- 
spond with the larger native oligomeric form having a molecu- 
lar mass above 200 kDa. However, we could not characterize 
the purified tetrameric Ig-CRH precisely, because of the low 
yield of the purification. 
3.3. Tetramerization of Ig-CRH induced by ligand 
To analyze the effect of the ligand G-CSF upon the oligom- 
erization of the Ig-CRH, the size of the complex of purified 
dimeric Ig-CRH (85 kDa) and the G-CSF (19 kDa) was estab- 
lished by separating mixtures of them (in ratios of 1: 10, 1: 1, 
1: 0.5, 1: 0.1 and 1: 0) by gel filtration on TSK gel G3000 SW 
HPLC (Fig. 2A). At a 1: 1 ratio of Ig-CRH to G-CSF, virtually 
all the protein chromatographed at the position of a molecular 
mass of 20&250 kDa, which corresponds to that of a complex 
composed of tetrameric Ig-CRH. When the ratio of Ig-CRH 
to G-CSF is 1: 10, excess free G-CSF (19 kDa) peak was pres- 
ent. Dissociation of the 200-250 kDa peak and appearance of 
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Fig. 1. Purification of Ig-CRH of G-CSF receptor. Panel A shows a schematic representation of the Ig-CRH of the murine G-CSF receptor [6]. SS, 
FNIII-like and TM indicate a signal sequence, fibronectin type III-like domain and a transmembrane domain, respectively. The thin bars in the G-CSF 
receptor epresent conserved cysteine residues; the thick bar represents conserved WSXWS motif. Numbers indicate the amino acid number of the 
G-CSF receptor. Panel B shows the 0.1% SDS-12.5% PAGE (reducing and non-reducing conditions) and Western blotting (reducing condition) of 
the eluate from the G-CSF affinity column chromatography. The SDS-PAGE gels were stained with Coomassie brilliant blue. Western blotting was 
performed as described [8]. Arrow heads indicate the position of the Ig-CRH. The numbers how the sizes (kDa) of marker proteins in lane M. Panel 
C shows the TSK gel G3000 SW gel filtration HPLC profile of the G-CSF affinity column eluate. Arrows show molecular size markers (kDa). 
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Fig. 2. Gel filtration of Ig-CRH .G-CSF complexes. Panel A shows the gel filtration profile of various ratios of Ig-CRH to G-CSF corresponding 
to 1: 10. 1: 1. 1: 0.5. 1: 0.1. 1: 0 (tou to bottom tracing). The protein concentrations of Ia-CRH (fixed at 1.6 HIM) and G-CSF were calculated from 
the absorption at 280 nm (an Ais,, ‘Ois value of 1.83 and 0.74, respectively). This value was calculated using 1,576 M-‘.cm-’ for tyrosine and 5,225 
M-‘.cm-’ for tryptophan at 280 nm [21]. Protein mixtures were equilibrated for 90 min at 20°C in 20 mM sodium phosphate buffer (pH 
7.0) containing 0.2 M NaCl. Samples (80 ~1) were applied to a TSKgel G3000SW gel filtration HPLC and eluted with the same buffer at 0.5 ml/min. 
Peaks were monitored for absorbance at 280 nm. The elution positions of the molecular size markers (kDa) are indicated by arrows. Panel B shows 
the gel filtration profile of Ig-CRH . G-CSF complex at a low concentration of the G-CSF containing “‘1-G-CSF. Ratios of Ig-CRH to G-CSF were 
corresoonded to 1: 0.5. 1: 0.1. 1 : 0.02. 1: 0.0005 (ton to bottom tracina). The nrotein mixtures (50 ul) of the Ia-CRH (l&d at 2.2 uM) and various 
concentrations of the G-CSF’(mixed’with ‘z51-G~CSF fixed at 1.1 nM7 approximately 200,000 epd) ‘were luted by gel filtration ai sh’own in Panel 
A and counted for “‘1-G-CSF using a y counter (open circles; solid lines). The control elution profile of “‘1-G-CSF without Ig-CRH is also shown 
(shaded circles; shaded lines). 
that having a higher molecular mass did not occur. When the 
ratio was below 1: 1, a dimeric Ig-CRH (85 kDa) peak was 
present, whereas free G-CSF was absent. SDS-PAGE con- 
firmed that the 200-250 kDa peak was a complex between 
Ig-CRH and G-CSF. The composition of the peaks was ana- 
lyzed by molar ratio of the released amino-terminus amino acid 
of the ligand and the Ig-CRH using an automated gas-phase 
amino acid sequencer. From three separate 20&250 kDa peaks 
under various conditions (in the ratios 1: 10, 1: 1 and 1: 0. l), the 
molar ratio of the amino-termini of the Ig-CRH and the G-CSF 
in the ligand-induced tetramer was equal. The equal molar ratio 
of the Ig-CRH and the G-CSF in these 20&250 kDa peaks was 
also confirmed by a reverse phase HPLC analysis (data not 
shown). These data indicated that its stoichiometry was 4 to 4. 
At a ratio of Ig-CRH to G-CSF below 1: 0.1, the tetrameric 
complex was not the preferred protein product (Fig. 2A). Gel 
filtration of the Ig-CRH .G-CSF complex using ‘251-G-CSF 
showed that most of the ‘251-G-CSF chromatographed at the 
position of 94 kDa at an extremely low concentration of the 
ligand (1:0.0005 ratio of Ig-CRH to G-CSF) (Fig. 2B). When 
the ratio of Ig-CRH to G-CSF was increased, the position of 
the chromatographed “‘1-G-CSF migrated from 94 to 200-250 
kDa. The molecular mass of 94 kDa almost corresponded with 
that of dimeric Ig-CRH *G-CSF complex, such as 2 : 1 or 2 : 2. 
These results indicated that the preferred Ig-CRH .G-CSF 
complex was the dimeric form at the extremely low concentra- 
tion of G-CSF and converted to tetrameric form by the addi- 
tion of G-CSF. The 2 : 1 GH receptor .GH complex induced at 
the appropriate concentration of GH is reportedly the active 
form, whereas the 1: 1 complex induced at high concentration 
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Fig. 3. Reversibility of dimerization and tetramerization of Ig-CRH. 
The purified Ig-CRH was chromatographed as the dimer (85 kDa) by 
gel filtration using the TSKgel G30OOSW HPLC at pH 7.0 (top chart; 
Dimer pH 7.0). Tetramerization of the Ig-CRH was observed by addi- 
tion of an equal amount of G-CSF at pH 7.0 (second chart; addition 
of G-CSF). Dissociation of the Ig-CRH.G-CSF complex was per- 
formed in the incubation with 0.1 M Glycine-HCl buffer pH 2.0 at 25°C 
for 1 h. Resulting monomeric Ig-CRH (45 kDa) and G-CSF (19 kDa) 
were analyzed using the gel filtration HPLC at pH 2.0 (third chart; pH 
2.0). Re-dimerization ofthe Ig-CRH was observed by the gel filtration 
at pH 7.0, after the eluted monomeric Ig-CRH was incubated in20 mM 
sodium phosphate buffer pH 7.0 containing 0.2 M NaCl.(fourth chart, 
pH 7.0). Re-tetramerization of the Ig-CRH was produced by the addi- 
tion of G-CSF. (bottom chart readdition of G-CSF). Flow rate was 
performed at 0.5 mUmin and peaks were monitored for absorbance at
280 nm. 
of GH is the form inactive for signal transduction [4,15,16]. 
Similar 2 : 1 receptor. ligand complexes were also obtained 
using receptors for interferon-g and prolactin [ 17,181. Our data 
indicated the G-CSF induced oligomerization of Ig-CRH, like 
these receptors. However, the stoichiometry of the Ig-CRH.G- 
CSF complex was different from those reported. If the G-CSF 
receptor is inactivated at a high concentration of the ligand as 
found in the GH receptor [4], we might propose that the 4:4 
G-CSF receptor .G-CSF complex is the inactive form. Cer- 
tainly the size and the stoichiometry of the active form of the 
G-CSF receptor is still an open question. 
It has been reported that binding of interleukind to its recep- 
tor induced the disulfide-linked homo-dimerization of gpl30 
protein, which is a second chain of the interleukind receptor 
[19]. The Ig-CRH contains 14 cysteine residues. However, all 
dimeric and tetrameric forms of the Ig-CRH with and without 
the ligand were found to be the 45 kDa by SDS-PAGE under 
nonreducing conditions, suggesting that these oligomerizations 
are not caused by covalent bonding, such as that of disulfide 
bonds. When the tetrameric Ig-CRH.ligand complex was ex- 
posed to an acidic buffer of pH 2.0, the induced tetramer disso- 
ciated into monomeric Ig-CRH and G-CSF (Fig. 3). We con- 
firmed that the purified dimer also dissociated into monomers 
at pH 2.0 (data not shown). These results confirmed that the 
formation of dimers and tetramers is not mediated by covalent 
interaction. The noncovalent nature of oligomerization is fur- 
ther demonstrated by the reversibility of the oligomerization 
process. The dissociated monomeric Ig-CRH was re-dimerized 
quantitatively by neutralization with the buffer (Fig. 3). More- 
over, re-dimerized Ig-CRH was tetramerized by adding G- 
CSF. An additional control experiment showed that the unpu- 
rified monomeric Ig-CRH induced by adding excess G-CSF 
was the tetramer, according to the gel filtration HPLC profile 
(detected by a ‘?-G-CSF binding assay and Western blotting). 
This excluded the notion that an unknown modification of 
Ig-CRH during purification might cause the tetramerization. It
appears that the homo-dimer without the ligand and homo- 
tetramer in the presence of excess G-CSF is an intrinsic prop- 
erty of the receptor molecule in solution. This is different from 
the property of the GH receptor [16], although the Ig-CRH has 
a GH receptor-like structure. 
Many oligomeric proteins contain identical subunit control 
metabolism and signal transduction. During these events, in- 
trinsic properties such as homo-oligomeric structures should 
play a crucial role for the regulation of activities of these pro- 
teins. A detailed biochemical explanation of the molecular basis 
of the homo-oligomeric structure has been proposed for allos- 
teric proteins and only a few receptors [1,2,20]. Thus, our find- 
ing of homo-oligomeric Ig-CRHs and the study of their mech- 
anism in solution should be of interest. The Ig-CRH of the 
G-CSF receptor contains an Ig domain (Fig. lA), whereas 
extracellular regions of receptors for GH, interferon-y and 
prolactin are composed of only the CRH region [3]. The effect 
of the Ig domain might be important for the homodimerization 
and homotetramerization of the G-CSF receptor. 
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